Related references
Note: Only part of the references are listed.Treatment of relapsing-remitting multiple sclerosis: current approaches and unmet needs
Aaron E. Miller et al.
CURRENT OPINION IN NEUROLOGY (2012)
Multiple sclerosis
Alyssa Nylander et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Sex-related factors in multiple sclerosis susceptibility and progression
Rhonda R. Voskuhl et al.
NATURE REVIEWS NEUROLOGY (2012)
Dopaminergic Modulation of CD4+CD25high Regulatory T Lymphocytes in Multiple Sclerosis Patients during Interferon-β Therapy
Marco Cosentino et al.
NEUROIMMUNOMODULATION (2012)
The Mechanism of Action of Interferon-beta in Relapsing Multiple Sclerosis
Bernd C. Kieseier
CNS DRUGS (2011)
Beta-interferon for multiple sclerosis
Richard A. Rudick et al.
EXPERIMENTAL CELL RESEARCH (2011)
Human FoxP3+CD4+ regulatory T cells: their knowns and unknowns
Makoto Miyara et al.
IMMUNOLOGY AND CELL BIOLOGY (2011)
Dopamine Induces IL-6-Dependent IL-17 Production via D1-Like Receptor on CD4 Naive T Cells and D1-Like Receptor Antagonist SCH-23390 Inhibits Cartilage Destruction in a Human Rheumatoid Arthritis/SCID Mouse Chimera Model
Kazuhisa Nakano et al.
JOURNAL OF IMMUNOLOGY (2011)
α1-Adrenergic Receptors Positively Regulate Toll-Like Receptor Cytokine Production from Human Monocytes and Macrophages
Laurel A. Grisanti et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
Jean-Martin Beaulieu et al.
PHARMACOLOGICAL REVIEWS (2011)
A Randomized Controlled Double-Masked Trial of Albuterol Add-on Therapy in Patients With Multiple Sclerosis
Samia J. Khoury et al.
ARCHIVES OF NEUROLOGY (2010)
The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability
Antonio Scalfari et al.
BRAIN (2010)
The immunoregulatory role of dopamine: An update
Chandrani Sarkar et al.
BRAIN BEHAVIOR AND IMMUNITY (2010)
Increasing CNS Noradrenaline Reduces EAE Severity
Maria Vittoria Simonini et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2010)
The changing demographic pattern of multiple sclerosis epidemiology
Nils Koch-Henriksen et al.
LANCET NEUROLOGY (2010)
Astrocytes as potential targets to suppress inflammatory demyelinating lesions in multiple sclerosis
Jacques De Keyser et al.
NEUROCHEMISTRY INTERNATIONAL (2010)
The interplay between the immune and central nervous systems in neuronal injury
V. Wee Yong et al.
NEUROLOGY (2010)
Multiple sclerosis immunology The healthy immune system vs the MS immune system
Lloyd H. Kasper et al.
NEUROLOGY (2010)
Alterations of the dopamine transporter in resting lymphocytes of patients with different psychotic disorders
Donatella Marazziti et al.
PSYCHIATRY RESEARCH (2010)
Disturbed regulatory T cell homeostasis in multiple sclerosis
Koen Venken et al.
TRENDS IN MOLECULAR MEDICINE (2010)
FOXP3+ regulatory T cells in the human immune system
Shimon Sakaguchi et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Role of dopamine in the physiology of T-cells and dendritic cells
Rodrigo Pacheco et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis
John S. Tzartos et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Antagonizing dopamine D1-like receptor inhibits Th17 cell differentiation: Preventive and therapeutic effects on experimental autoimmune encephalomyelitis
Kazuhisa Nakano et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Therapy with interferon-beta modulates endogenous catecholamines in lymphocytes of patients with multiple sclerosis
Mauro Zaffaroni et al.
EXPERIMENTAL NEUROLOGY (2008)
Hypoperfusion of the cerebral white matter in multiple sclerosis: possible mechanisms and pathophysiological significance
Jacques De Keyser et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2008)
The role of regulatory T cells in multiple sclerosis
Alla L. Zozulya et al.
NATURE CLINICAL PRACTICE NEUROLOGY (2008)
Phagocyte-derived catecholamines enhance acute inflammatory injury
Michael A. Flierl et al.
NATURE (2007)
Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation
Hania Kebir et al.
NATURE MEDICINE (2007)
Hyperprolactinemia and autoimmune diseases
Hedi Orbach et al.
AUTOIMMUNITY REVIEWS (2007)
Autonomic innervation and regulation of the immune system (1987-2007)
Dwight M. Nance et al.
BRAIN BEHAVIOR AND IMMUNITY (2007)
MPTP-induced central dopamine depletion exacerbates experimental autoimmune encephalomyelitis (EAE) in C57BL mice
E. Balkowiec-Iskra et al.
INFLAMMATION RESEARCH (2007)
Interferon-beta - Mechanism of action and dosing issues
Clyde E. Markowitz
NEUROLOGY (2007)
The safety and efficacy of IFN-β products for the treatment of multiple sclerosis
Marcelo Kremenchutzky et al.
EXPERT OPINION ON DRUG SAFETY (2007)
Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop
Marco Cosentino et al.
BLOOD (2007)
The neurobiology of multiple sclerosis: Genes, inflammation, and neurodegeneration
Stephen L. Hauser et al.
NEURON (2006)
Therapeutic role of beta-interferons in multiple sclerosis
A Javed et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Immunopathogenesis and immunotherapy of multiple sclerosis
B Hemmer et al.
NATURE CLINICAL PRACTICE NEUROLOGY (2006)
Medical progress: Multiple sclerosis - The plaque and its pathogenesis
EM Frohman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Autonomic dysfunction in multiple sclerosis
CA Haensch et al.
JOURNAL OF NEUROLOGY (2006)
Dopamine by itself activates either D2, D3 or D1/D5 dopaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNFα or both
MJ Besser et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Dopamine fails to regulate activation of peripheral blood lymphocytes from multiple sclerosis patients:: Effects of IFN-β
M Giorelli et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2005)
Interferon-γ and interferon-β affect endogenous catecholamines in human peripheral blood mononuclear cells:: Implications for multiple sclerosis
M Cosentino et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
The CD4-Thl model for multiple sclerosis: a crucial re-appraisal
H Lassmann et al.
TRENDS IN IMMUNOLOGY (2004)
Dopaminergic D1-like receptor-dependent inhibition of tyrosine hydroxylase mRNA expression and catecholamine production in human lymphocytes
M Ferrari et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Astrocytic β2-adrenergic receptors and multiple sclerosis
J De Keyser et al.
NEUROBIOLOGY OF DISEASE (2004)
Post-receptorial mechanisms underlie functional disregulation of β2-adrenergic receptors in lymphocytes from multiple sclerosis
M Giorelli et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Antipsychotic treatment of psychosis associated with multiple sclerosis
E Davids et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2004)
The two faces of L-DOPA: benefits and adverse side effects in the treatment of Encephalitis lethargica, Parkinson's disease, multiple sclerosis and amyotrophic lateral sclerosis
HD Foster et al.
MEDICAL HYPOTHESES (2004)
Erratum: The CD4-Th1 model for multiple sclerosis: a crucial re-appraisal (vol 25, pg 132, 2004)
H Lassmann et al.
TRENDS IN IMMUNOLOGY (2004)
Unravelling dopamine (and catecholamine) physiopharmacology in lymphocytes: open questions
M Cosentino et al.
TRENDS IN IMMUNOLOGY (2003)
Immunomodulation in multiple sclerosis: from immunosuppression to neuroprotection
O Neuhaus et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2003)
Expression of β2 adrenoreceptors on peripheral blood mononuclear cells in patients with primary and secondary progressive multiple sclerosis:: a longitudinal six month study
Y Zoukos et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2003)
Use of Ephedra-containing products and risk for hemorrhagic stroke
LB Morgenstern et al.
NEUROLOGY (2003)
Ultrastructural localization of tyrosine hydroxylase in human peripheral blood mononuclear cells: effect of stimulation with phytohaemagglutinin
M Reguzzoni et al.
CELL AND TISSUE RESEARCH (2002)
Catecholamine production and tyrosine hydroxylase expression in peripheral blood mononuclear cells from multiple sclerosis patients: effect of cell stimulation and possible relevance for activation-induced apoptosis
M Cosentino et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Stimulation with phytohaemagglutinin induces the synthesis of catecholamines in human peripheral blood mononuclear cells: role of protein kinase C and contribution of intracellular calcium
M Cosentino et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Monoamine neurotoxins-induced apoptosis in lymphocytes by a common oxidative stress mechanism:: involvement of hydrogen peroxide (H2O2), caspase-3, and nuclear factor kappa-B (NF-κB), p53, c-Jun transcription factors
MJ Del Rio et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Catecholamine levels in peripheral blood lymphocytes from multiple sclerosis patients
C Rajda et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Potential of beta(2)-adrenoceptor agonists as add-on therapy for multiple sclerosis - Focus on salbutamol (albuterol)
K Makhlouf et al.
CNS DRUGS (2002)
Upregulation of lymphocyte apoptosis as a strategy for preventing and treating autoimmune disorders: a role for whole-food vegan diets, fish oil and dopamine agonists
MF McCarty
MEDICAL HYPOTHESES (2001)
Circulating dopamine level, in lung carcinoma patients, inhibits proliferation and cytotoxicity of CD4+and CD8+T cells by D1 dopamine receptors: an in vitro analysis
B Saha et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2001)
IFN-gamma production by Th1 cells generated from naive CD4(+) T cells exposed to norepinephrine
MA Swanson et al.
JOURNAL OF IMMUNOLOGY (2001)
HPLC-ED measurement of endogenous catecholamines in human immune cells and hematopoietic cell lines
M Cosentino et al.
LIFE SCIENCES (2000)
Medical progress: Multiple sclerosis.
JH Noseworthy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
[3H]dihydroalprenolol binding to beta adrenergic receptors in multiple sclerosis brain
E Zeinstra et al.
NEUROSCIENCE LETTERS (2000)
Dopamine, a neurotransmitter, influences the immune system
S Basu et al.
JOURNAL OF NEUROIMMUNOLOGY (2000)